Please use this identifier to cite or link to this item: http://10.9.150.37:8080/dspace//handle/atmiyauni/1657
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPansuriya, K.-
dc.contributor.authorLalpara, J. N.-
dc.contributor.authorHadiyal, S. D.-
dc.contributor.authorDhaduk, B. B.-
dc.contributor.authorDubal, G. G.-
dc.date.accessioned2024-11-19T04:53:31Z-
dc.date.available2024-11-19T04:53:31Z-
dc.date.issued2022-
dc.identifier.citationPansuriya, K., Lalpara, J. N., Hadiyal, S. D., Dhaduk, B. B., & Dubal, G. G. (2022). Trimethylsilyl chloride catalyzed synthesis of fluoro substituted tetrahydropyrimidines: Molecular docking and antidiabetic studies. Chemical Data Collections, 41, 100904.en_US
dc.identifier.urihttp://10.9.150.37:8080/dspace//handle/atmiyauni/1657-
dc.description.abstractA novel series of tetrahydropyrimidine derivatives containing azepino indole and aryl substitution was achieved by a multicomponent synthetic approach using Biginelli condensation. Various catalysts were employed in the reactions for yield increment but trimethylsilyl chloride gave the highest yield. Moreover, all synthesized molecules were checked for in vitro antidiabetic poten- tial. In addition, molecular docking of these synthesized molecules was studied using barley alpha-amylase isozyme 1 (amy1) (1RPK). The result revealed that compounds 4a and 4c have a good inhibitory potentialen_US
dc.language.isoenen_US
dc.publisherChemical Data Collections,en_US
dc.subjectTetrahydropyrimidinesen_US
dc.subjectTrimethylsilyl chlorideen_US
dc.subjectAntidiabetic activityen_US
dc.subjectMolecular dockingen_US
dc.titleTrimethylsilyl chloride catalyzed synthesis of fluoro substituted tetrahydropyrimidines: Molecular docking and antidiabetic studiesen_US
dc.typeArticleen_US
Appears in Collections:01. Journal Articles

Files in This Item:
File Description SizeFormat 
Trimethylsilyl chloride catalyzed synthesis of fluoro substituted.pdf1.17 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.